Carespas CP (300+25) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Care Formulations. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Paracetamol, Camylofin. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 45 (arround $0.63 US Dollar)
Generic (Salt) Combination :
(Paracetamol+ Camylofin)
Pharma Company :
Care Formulations
Brand Label :
Carespas CP (300+25)
Preparation Type :
Tablet
Single Dose :
1 Tablet
Composition (Fixed-Dose Combination) :
Paracetamol-300 mg
Camylofin-25 mg
Pack Size/Qty/Vol :
10 Tablet
Price Unit :
Rs 4.5 INR (arround $0.063 US Dollar)
Price Pack :
Rs 45 INR (arround $0.63 US Dollar)
Drug details for Carespas CP (300+25)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Carespas CP (300+25) are :
Paracetamol-300 mg
Camylofin-25 mg
Paracetamol Indication (Prescribed for or used as): Analgesic and antipyretic.
For more details on Paracetamol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Paracetamol..
Camylofin Indication (Prescribed for or used as): Biliary colic, dysmenorrhoea, intestinal colic, renal colic.
For more details on Camylofin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Camylofin..
Carespas CP (300+25) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 1 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Carespas CP (300+25), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Paracetamol-300 mg Camylofin-25 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.